High materiality8/10
Monopar Therapeutics price target raised to $145 from $128 at Barclays
Why it may matterVerify against the original reporting
Upgrade supports upside risk; potential catalysts ahead.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises MNPR target to $145; current price ~ $109.96.
- Barclays target $145; price $109.96.
Key facts
- 01
Target: $145
- 02
Posted price: $109.96
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.